Sedative, hypnotic or anxiolytic use, unspecified with sedative, hypnotic or anxiolytic-induced psychotic disorder
ICD-10 F13.95 is a billable code used to indicate a diagnosis of sedative, hypnotic or anxiolytic use, unspecified with sedative, hypnotic or anxiolytic-induced psychotic disorder.
F13.95 refers to a condition characterized by the use of sedatives, hypnotics, or anxiolytics that leads to a psychotic disorder. This code is used when the specific substance is not identified, but the individual exhibits symptoms of psychosis, such as hallucinations, delusions, or disorganized thinking, as a direct result of sedative or anxiolytic use. Patients may present with altered mental status, impaired judgment, and significant distress. The psychotic symptoms can occur during intoxication or withdrawal phases and may require immediate medical intervention. Treatment often involves stabilization, supportive care, and possibly the use of antipsychotic medications. Long-term management may include substance use disorder treatment programs focusing on behavioral therapies and support groups to address the underlying addiction.
Detailed mental status examination and substance use history.
Patients presenting with acute psychosis following sedative use.
Ensure clear documentation of the timeline of substance use and onset of psychotic symptoms.
Comprehensive assessment of substance use patterns and treatment history.
Patients in withdrawal experiencing psychotic symptoms.
Document any co-occurring mental health disorders and treatment interventions.
Used for follow-up visits in patients with substance use disorders.
Document history of present illness, review of systems, and treatment plan.
Ensure that the visit includes a comprehensive assessment of mental health status.
Key symptoms include hallucinations, delusions, disorganized thinking, and significant changes in behavior that occur during or shortly after the use of sedatives, hypnotics, or anxiolytics.
